arrow
C

Chiara Biagioni

azienda usl toscana centro
H指数:19
被引数:1,478

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A computational framework for sensitive tumor detection and accurate subtyping using shallow cell-free DNA methylome sequencing

使用浅细胞游离DNA甲基化测序进行敏感肿瘤检测和准确分型的计算框架

2026-02-030
OAAI
Enabling sensitive and precise detection of ctDNA through somatic copy number aberrations in breast cancer

通过体细胞拷贝数异常实现乳腺癌中ctDNA的敏感与精确检测

2025-03-080
OA
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial
2024-12-010
PRE
Impact of geriatrician-implemented Interventions on chemotherapy (CT) delivery in vulnerable elderly patients with early or advanced solid tumors: The GIVE trial

老年科医生实施的干预措施对早期或晚期实体瘤易感老年患者化疗(CT)给药的影响:GIVE试验

2024-09-010
PRE
Sensitive tumor detection, accurate quantification, and ER subtyping using low-pass methylome of liquid biopsy samples from patients (pts) with metastatic breast cancer (mBC)
2024-05-020
PRE
Clinical and Genomic Features of ER-Positive/HER2-negative Metastatic Breast Cancer in AURORA Molecular Screening Initiative (BIG 14-01): Mechanisms of Endocrine Therapy Resistance and Implications for Adjuvant Approaches
2024-05-020
PRE
Prognostic and predictive role of RBsig and CCNE1/RB1 gene-expression signatures in patients with advanced breast cancer treated with palbociclib in combination with endocrine therapy in the PALOMA-2 and 3 trials
2023-03-010
PRE
Serum thymidine kinase activity as a prognostic marker in women with metastatic breast cancer treated with two different schedules of palbociclib plus second-line endocrine therapy within the CCTG MA38 trial
2023-03-010
PRE
Circulating tumor cells, immunohistochemical subtypes, and genes mutation as prognostic markers in HER2 negative metastatic breast cancer patients candidates to chemotherapy
2023-03-010
PRE
Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial

ER阳性,HER2-negative晚期乳腺癌患者的循环肿瘤细胞和palbociclib治疗: TREnd试验的转化子研究结果

2021-03-2418
OAAI